Background: Clinical trials evaluating the effect of probiotics on cardiovascular intermediate outcomes have been scarce in recent years. We systematically evaluated the efficacy of probiotics on intermediate cardiovascular outcomes in patients with overweight or obesity.
Methods: We searched for randomized controlled trials (RCTs) in four databases (until August 2021) that evaluated the effects of probiotics versus controls on intermediate cardiovascular outcomes. The outcomes were body mass index (BMI), weight, systolic blood pressure (SBP), diastolic blood pressure (DBP), glucose, low-density lipoprotein (LDL), and high-density lipoprotein (HDL) levels. Inverse variance random effects meta-analyses were used. The effects were reported as mean difference (MD), with their 95% confidence intervals (95% CI). The quality of evidence (QoE) was assessed with GRADE (grading of recommendations, assessment, development and evaluations) methodology.
Results: A total of 25 RCTs were included (n = 2170), with a range of follow-up from two to six months. Probiotics likely reduced BMI (MD -0.27 kg/m, 95%CI: -0.35 to -0.19; 17 RCTs; I2 = 26%, QoE: moderate), as well as likely reduced weight (MD -0.61 kg, 95%CI: -0.89 to -0.34; 15 RCTs; I2 = 0%, QoE: moderate), and may have slightly reduce LDL (MD -4.08 mg/dL; 95%CI: -6.99 to -1.17; 9 RCTs; I2 = 87%, QoE: low) in comparison to the controls. However, probiotics had no effect on SBP (MD -0.40 mmHg; 95%CI: -5.04 to 4.25; 7 RCTs; I2 = 100%, QoE: very low), DBP (MD -1.73 mmHg; 95%CI: -5.29 to 1.82; 5 RCTs; I2 = 98%, QoE: very low), glucose (MD -0.07 mg/dL; 95%CI -0.89 to 0.75; I2 = 96%, QoE: very low), HDL (MD -1.83 mg/dL; 95%CI: -4.14 to 2.47; 14 RCTs; I2 = 98%, QoE: very low), or triglycerides (MD -3.29 mg/dL, 95%CI -17.03 to 10.45; 14 RCTs, I2 = 95%, QoE: very low) compared to control arms, and the evidence was very uncertain.
Conclusions: In obese or overweight patients, BMI, weight, and LDL were lower in patients who received probiotics compared to those who received controls. Other lipids, glucose, and blood pressure were not affected by the probiotics.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095238 | PMC |
http://dx.doi.org/10.3390/jcm12072554 | DOI Listing |
We systematically evaluated effects of Mediterranean diets (MED) on cardiovascular (CV) disease and risk factors in overweight or obese adults. Five engines and two registries were searched until October 2023 for randomized controlled trials (RCTs) evaluating any type of MED compared to other diets or advice in adults. Outcomes of interest were clinical outcomes and CV risk factors (anthropometric, lipids, blood pressure, glucose metabolism, liver function).
View Article and Find Full Text PDFSensors (Basel)
July 2024
School of Engineering and Technology, Central Queensland University, Rockhampton 4701, Australia.
Am J Respir Crit Care Med
December 2024
Division of Sleep and Circadian Disorders, Department of Medicine, and Department of Neurology, Brigham & Women's Hospital and Harvard Medical School, Boston, Massachusetts; and.
Low arousal threshold and poor muscle responsiveness are common determinants of obstructive sleep apnea (OSA). Hypnotics were hypothesized as an alternative OSA treatment via raising the arousal threshold and possibly genioglossus responsiveness. To examine the effect of common hypnotics on arousal threshold, OSA severity, and genioglossus responsiveness.
View Article and Find Full Text PDFInt Dent J
December 2024
Unidad de Revisiones Sistemáticas y Meta-análisis (URSIGET), Vicerrectorado de Investigación, Universidad San Ignacio de Loyola, Lima, Peru.; Health Outcomes, Policy, and Evidence Synthesis (HOPES) group, University of Connecticut School of Pharmacy, Storrs, Connecticut, USA. Electronic address:
Objectives: We aim to compare efficacy and safety of water vapour therapy (Rezūm), transurethral needle ablation (TUNA) and transurethral microwave therapy (TUMT) for treating men with moderate to severe benign prostatic hyperplasia (BPH) symptoms.
Materials: PubMed/MEDLINE, EMBASE and Cochrane Library were searched from inception to 30 July 2023, followed by reference searching and dual-independent study selection. We analysed only randomized clinical trials.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!